Data / Research funding / Lewy Body Dementia
Lewy Body Dementia: 283 NIH awards ($469.7M) to 93 organizations
283 NIH awards ($469.7M) in the NIH spending category Lewy Body Dementia, to 93 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
283 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Mayo Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $18,486,241 | July 1, 2019 | April 30, 2029 | BOEVE, BRADLEY F | reporter.nih.gov |
| 1Florida Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $13,348,245 | June 15, 2020 | April 30, 2027 | SMITH, GLENN E. | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $6,563,373 | September 30, 2016 | August 31, 2027 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies | NIH | National Institute on Aging | 2025 | $5,174,076 | September 1, 2025 | August 31, 2029 | VAZIRI, ASHKAN | reporter.nih.gov |
| Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $4,943,234 | September 15, 2022 | June 30, 2027 | SEYFRIED, NICHOLAS THOMAS | reporter.nih.gov |
| Assessing Novel Biomarkers for Cognitive Fluctuations in DLB | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $4,924,374 | September 1, 2025 | July 31, 2029 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis | NIH | National Institute on Aging | 2023 to 2025 | $4,683,243 | September 15, 2023 | May 31, 2029 | BERMAN, SARAH B | reporter.nih.gov |
| African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies | NIH | National Institute on Aging | 2021 to 2023 | $4,504,699 | September 15, 2016 | May 31, 2024 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Structural Biology of Alpha-Synuclein in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $4,231,530 | September 30, 2018 | August 31, 2026 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $4,170,328 | December 15, 2021 | June 30, 2026 | CHEN, SHU G. | reporter.nih.gov |
| Skin biomarkers for diagnosing and characterizing AD and ADRD | NIH | National Institute on Aging | 2021 to 2025 | $3,834,262 | September 30, 2021 | June 30, 2027 | KRAUS, ALLISON L | reporter.nih.gov |
| Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,826,830 | August 1, 2015 | June 30, 2027 | SINGER, WOLFGANG | reporter.nih.gov |
| Elucidating the Biological Differences Between Distinct Fibrillar and Non-Fibrillar Alpha-Synuclein Inclusions in Human Stem-Cell Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,706,946 | July 1, 2020 | April 30, 2026 | KHURANA, VIKRAM | reporter.nih.gov |
| IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD) | NIH | National Institute on Aging | 2024 to 2025 | $3,640,661 | June 5, 2024 | May 31, 2029 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,568,423 | July 15, 2021 | May 31, 2027 | ZHAO, GUOYAN | reporter.nih.gov |
| Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD) | NIH | National Institute on Aging | 2021 to 2023 | $3,567,627 | March 15, 2019 | November 30, 2025 | DAMS-O'CONNOR, KRISTEN | reporter.nih.gov |
| Region-Specific Vulnerability of the Lewy Body Dementia's Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,557,900 | August 1, 2021 | June 30, 2027 | NA, CHAN-HYUN | reporter.nih.gov |
| More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,433,868 | September 15, 2016 | September 30, 2026 | KLUGER, BENZI M | reporter.nih.gov |
| A randomized, double blind, placebo-controlled study to evaluate the impact of Nilotinib treatment on safety, tolerability, pharmacokinetics and biomarkers in Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2021 to 2022 | $3,210,062 | July 1, 2019 | April 30, 2025 | MOUSSA, CHARBEL | reporter.nih.gov |
| Spatial organization and conformational ensembles of amyloids inside cells | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,178,675 | August 13, 2025 | July 31, 2029 | FREDERICK, KENDRA KING | reporter.nih.gov |
| Deep Phenotypic Characterization of Prodromal Dementia with Lewy Bodies | NIH | National Institute on Aging | 2022 | $3,171,435 | September 30, 2022 | August 31, 2025 | GALVIN, JAMES E | reporter.nih.gov |
| Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders | NIH | National Institute on Aging | 2022 to 2025 | $3,140,565 | June 1, 2022 | March 31, 2027 | KREILING, JILL | reporter.nih.gov |
| Preclinical Markers of Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,073,020 | August 1, 2021 | June 30, 2027 | VAILLANCOURT, DAVID E | reporter.nih.gov |
| Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates | NIH | National Institute on Aging | 2022 to 2025 | $3,065,392 | September 30, 2022 | May 31, 2027 | SOTO, CLAUDIO | reporter.nih.gov |
| Anxiety and depression in a nonhuman primate model of synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,064,072 | August 4, 2025 | July 31, 2029 | EMBORG, MARINA | reporter.nih.gov |
| Investigating the Causal Role of Particulate Matter Components on Lewy Body Dementia: Integrating Epidemiologic and Mechanistic Evidence | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,013,265 | August 1, 2025 | July 31, 2029 | PARKS, ROBBIE M | reporter.nih.gov |
| Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,977,682 | September 23, 2021 | August 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Single-Nuclei Multiomic Analysis of DLB Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,970,479 | August 17, 2022 | July 31, 2027 | KIM, YOON-SEONG | reporter.nih.gov |
| Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS) | NIH | National Institute on Aging | 2022 to 2024 | $2,933,352 | September 30, 2016 | May 31, 2026 | BERKA, CHRIS | reporter.nih.gov |
| Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,919,989 | September 23, 2022 | August 31, 2026 | EITAN, EREZ | reporter.nih.gov |
| Brainstem-based imaging biomarkers of premanifest synucleinopathy | NIH | National Institute on Aging | 2021 to 2024 | $2,913,904 | May 15, 2020 | April 30, 2026 | BIANCIARDI, MARTA | reporter.nih.gov |
| Vitamin K and D and Cognitive Impairment in Older Adults | NIH | National Institute on Aging | 2022 to 2025 | $2,723,572 | September 1, 2016 | March 31, 2027 | BOOTH, SARAH LOUISE | reporter.nih.gov |
| Structure-function relationships in alpha-synuclein strain biology | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,674,385 | August 15, 2025 | July 31, 2029 | WOERMAN, AMANDA L. | reporter.nih.gov |
| Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study | NIH | National Institute on Aging | 2021 to 2024 | $2,662,829 | September 15, 2020 | April 30, 2026 | ARMSTRONG, MELISSA JO | reporter.nih.gov |
| Adding technology that will enhance commercialization of our neuroscience-based innovative assistive technology platform for living with Alzheimer's disease and Alzheimer's disease related dementia | NIH | National Institute on Aging | 2024 to 2025 | $2,660,575 | May 15, 2024 | April 30, 2027 | GOLDEN, MATTHEW | reporter.nih.gov |
| Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,637,479 | August 1, 2023 | July 31, 2028 | RYMAN, SEPHIRA | reporter.nih.gov |
| Developing Protein-based MRI Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $2,630,332 | September 15, 2020 | May 31, 2026 | ZHOU, JINYUAN | reporter.nih.gov |
| The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,609,788 | September 20, 2019 | August 31, 2025 | POSTON, KATHLEEN LOMBARD | reporter.nih.gov |
| Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,549,857 | August 19, 2022 | July 31, 2027 | BRONTE-STEWART, HELEN | reporter.nih.gov |
| Citalopram as a posterior cortical protective therapy in Parkinson disease | NIH | National Institute on Aging | 2021 to 2024 | $2,545,093 | August 15, 2020 | April 30, 2026 | KOTAGAL, VIKAS | reporter.nih.gov |
| Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,493,768 | August 1, 2023 | July 31, 2028 | KHURANA, VIKRAM | reporter.nih.gov |
| The role of a-synuclein accumulation in lysosomal hydrolase trafficking and function | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,474,168 | August 1, 2015 | April 30, 2027 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat | NIH | National Institute on Aging | 2023 to 2025 | $2,463,125 | May 1, 2023 | March 31, 2028 | GOMPERTS, STEPHEN N. | reporter.nih.gov |
| Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreadingof neurodegenerative disease | NIH | National Institute on Aging | 2021 to 2024 | $2,409,422 | May 1, 2020 | February 28, 2026 | LEE, JIN HYUNG | reporter.nih.gov |
| A Diagnostic Test for Dementia with Lewy Bodies | NIH | National Institute on Aging | 2022 to 2023 | $2,408,271 | April 1, 2022 | March 31, 2026 | LEVINE, TODD | reporter.nih.gov |
| Interaction between microvascular function and CSF clearance in Lewy body dementia | NIH | National Institute on Aging | 2023 | $2,387,139 | June 1, 2023 | May 31, 2026 | HUA, JUN | reporter.nih.gov |
| Dissecting the Etiology of The Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,383,188 | May 1, 2022 | April 30, 2025 | FINKBEINER, STEVEN M | reporter.nih.gov |
| The Impact of Beta- and Gamma-synucleins on Alpha-synuclein's Synaptic Function | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,342,275 | May 1, 2023 | March 31, 2024 | BURRE, JACQUELINE | reporter.nih.gov |
| Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,336,166 | August 15, 2022 | July 31, 2025 | MACKINNON, COLUM D | reporter.nih.gov |
| Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,335,086 | September 15, 2021 | August 31, 2025 | BEACH, THOMAS G | reporter.nih.gov |
| Investigations of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,332,494 | September 23, 2021 | August 31, 2026 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $2,315,618 | August 1, 2016 | June 30, 2027 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Leveraging a Natural Experiment to Determine the Effects of Integrated Palliative Care on Health Service Outcomes and Disparities in Parkinson Disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,307,536 | August 21, 2023 | July 31, 2026 | WILLIS, ALLISON | reporter.nih.gov |
| Determine the role of atmospheric particulate matter pollutants in contributing to Lewy Body Dementia | NIH | National Institute on Aging | 2023 | $2,296,059 | April 15, 2023 | March 31, 2026 | MAO, XIAOBO | reporter.nih.gov |
| Novel fibril-selective nanobody-based agents targeting intracellular and extracellular α-synuclein aggregates and prion-like propagation induced dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,280,379 | September 19, 2024 | August 31, 2027 | WANG, WENJING | reporter.nih.gov |
| Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder | NIH | National Institute on Aging | 2025 | $2,276,803 | September 1, 2023 | August 31, 2028 | HOWELL, MICHAEL J | reporter.nih.gov |
| Propagation of Lewy pathology in Parkinson's and related disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,263,224 | March 13, 2015 | November 30, 2026 | LUK, KELVIN C | reporter.nih.gov |
| Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading | NIH | National Institute on Aging | 2021 to 2025 | $2,261,713 | September 30, 2021 | May 31, 2027 | MAO, XIAOBO | reporter.nih.gov |
| Molecular and Network Analyses of Lewy Body Dementia Pathogenesis | NIH | National Institute on Aging | 2021 | $2,252,599 | September 5, 2021 | August 31, 2024 | CHIN, LIH-SHEN | reporter.nih.gov |
| Worldwide Tractometry Initiative to Investigate Brain Microstructure, Cognitive Impairment & Dementia in Parkinsons Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,243,095 | June 1, 2024 | May 31, 2027 | THOMPSON, PAUL M | reporter.nih.gov |
| Vulnerability of the ascending arousal network to alpha-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,234,905 | September 18, 2024 | August 31, 2027 | ALDRIDGE, GEORGINA | reporter.nih.gov |
| Peripheral Biomarkers for Early Diagnosis of Mixed Pathologies in AD/ADRD | NIH | National Institute on Aging | 2023 to 2025 | $2,219,859 | June 1, 2023 | February 29, 2028 | CHEN, SHU G. | reporter.nih.gov |
| Identification and Verification of S-Nitrosylated Proteins in Bodily Fluids as Biomarkers for Parkinson's Disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,199,931 | July 1, 2021 | June 30, 2025 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,192,915 | August 19, 2022 | July 31, 2024 | BRONTE-STEWART, HELEN | reporter.nih.gov |
| How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,192,716 | August 1, 2023 | July 31, 2026 | DETTMER, ULF | reporter.nih.gov |
| Mechanisms of gene regulation and RNA processing in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,181,405 | July 1, 2020 | June 30, 2025 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| PERSEVERE in Lewy Body Dementia: A Randomized, Controlled Trial of Peer Mentor Support and Caregiver Education | NIH | National Institute on Aging | 2023 to 2025 | $2,167,105 | August 15, 2023 | June 30, 2028 | FLEISHER, JORI ERIN | reporter.nih.gov |
| Biomarkers of cognitive decline in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,148,559 | September 19, 2019 | June 30, 2024 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,147,422 | August 15, 2019 | May 31, 2025 | KONG, QINGZHONG | reporter.nih.gov |
| α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,133,267 | March 1, 2022 | February 28, 2025 | MAO, XIAOBO | reporter.nih.gov |
| Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,121,853 | July 15, 2022 | April 30, 2025 | DETTMER, ULF | reporter.nih.gov |
| Use of wearable sensors to improve the early diagnosis of DLB | NIH | National Institute on Aging | 2022 to 2024 | $2,120,721 | September 15, 2019 | August 31, 2026 | TSUANG, DEBBY WEN | reporter.nih.gov |
| Slow wave sleep as a biomarker of rehabilitation-induced cognitive improvement in Parkinson's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,113,374 | April 1, 2021 | March 31, 2027 | AMARA, AMY WILLIS | reporter.nih.gov |
| Mechanisms of Synaptic Dysfunction in Parkinson's and Other Synuclein-Linked Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $2,092,085 | June 1, 2022 | May 31, 2025 | MORGAN, JENNIFER REBECCA | reporter.nih.gov |
| S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,081,944 | August 1, 2021 | July 31, 2024 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Decoding the BETA-arrestin2-LMBRD2 cascade in ALPHA-synuclein pathogenesis. | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,069,215 | August 6, 2024 | July 31, 2027 | WOO, JUNGA "ALEXA" | reporter.nih.gov |
| Peripheral Tissue Biomarker for Premorten Diagnosis of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,065,446 | September 1, 2020 | June 30, 2025 | CHEN, SHU G. | reporter.nih.gov |
| MicroRNAs in CNS-derived extracellular microvesicles as peripheral blood biomarkers for Alzheimer disease | NIH | National Institute on Aging | 2021 to 2023 | $2,025,805 | March 1, 2019 | June 30, 2025 | SHI, MIN | reporter.nih.gov |
| Identifying genetically driven gene dysregulation in Alzheimer's disease and related dementias using statistical data integration | NIH | National Institute on Aging | 2023 to 2025 | $1,999,058 | April 1, 2023 | December 31, 2027 | VOLOUDAKIS, GEORGIOS | reporter.nih.gov |
| Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms | NIH | National Institute on Aging | 2021 to 2024 | $1,964,673 | September 15, 2020 | May 31, 2026 | FOSTER, ERIN | reporter.nih.gov |
| Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,957,052 | December 1, 2020 | November 30, 2026 | DAVIS, MARIE YNEZ | reporter.nih.gov |
| Elucidating the role of NK cells in Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,936,429 | February 1, 2021 | March 31, 2027 | LEE, JAE-KYUNG JAMISE | reporter.nih.gov |
| Smartphone phenotype collection for diagnostic screening of mild cognitive impairment | NIH | National Institute on Aging | 2021 to 2022 | $1,929,269 | September 30, 2018 | May 31, 2025 | ARMENTROUT, STEVEN L | reporter.nih.gov |
| Role of GlcSph in cognitive deficits in Lewy body dementias | NIH | National Institute on Aging | 2023 to 2025 | $1,911,743 | May 15, 2023 | March 31, 2028 | VOLPICELLI-DALEY, LAURA A. | reporter.nih.gov |
| Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,881,677 | September 1, 2020 | June 30, 2026 | MISHRA, VIRENDRA R | reporter.nih.gov |
| Linear predictive coding of EEG Activity for Diagnosis of Parkinson's Disease (LEAD-PD) | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,876,731 | June 1, 2023 | May 31, 2026 | UC, ERGUN Y | reporter.nih.gov |
| Airborne metals, neurodegeneration, and dementia in the Adult Changes in Thought study | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,847,274 | September 15, 2023 | June 30, 2028 | SUH, HELEN | reporter.nih.gov |
| Studying Aggregation in Neurodegenerative Disease using Synthetic Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,825,919 | February 15, 2019 | July 31, 2026 | PETERSSON, ERNEST JAMES | reporter.nih.gov |
| Proteostasis dysregulation and alpha-synuclein | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,813,410 | May 1, 2020 | April 30, 2025 | QI, XIN | reporter.nih.gov |
| Network and cellular vulnerability to pathological protein progression | NIH | National Institute on Aging | 2022 to 2025 | $1,808,647 | May 1, 2022 | April 30, 2027 | HENDERSON, MICHAEL | reporter.nih.gov |
| Role of APOE in endosomal processing of alpha-synuclein | NIH | National Institute on Aging | 2023 to 2024 | $1,757,895 | September 1, 2023 | August 31, 2025 | DAVIS, ALBERT A | reporter.nih.gov |
| Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 | $1,751,085 | May 15, 2021 | April 30, 2024 | RISSMAN, ROBERT | reporter.nih.gov |
| Fluorescent IRE sensor for synucleinopathy drug discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $1,728,231 | September 22, 2022 | August 31, 2025 | SHEN, WEN | reporter.nih.gov |
| Synergistic Enhancement of ER proteostasis, trafficking, and lysosomes as treatments for Dementia with Lewy bodies and Parkinson’s disease-dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,707,089 | August 15, 2024 | July 31, 2027 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Combinatorial effects of PTMs on a-Synuclein structure, function and aggregation | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,706,062 | April 15, 2022 | March 31, 2025 | RHOADES, ELIZABETH | reporter.nih.gov |
| Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,704,192 | August 1, 2023 | May 31, 2028 | THOMAS, BOBBY | reporter.nih.gov |
| Developing an Individualized Deep Connectome Framework for ADRD Analysis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $1,686,621 | August 18, 2022 | May 31, 2025 | ZHU, DAJIANG | reporter.nih.gov |
| Cortical Alpha-Synuclein in Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,683,467 | February 15, 2023 | January 31, 2028 | ALDRIDGE, GEORGINA | reporter.nih.gov |
| Reciprocal interactions between cortical circuit dysfunction and α-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,674,295 | February 1, 2023 | January 31, 2028 | ZEIGER, WILLIAM ABEL | reporter.nih.gov |
| Cholinergic Mechanisms in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,653,870 | April 1, 2023 | March 31, 2028 | MOEHLE, MARK S | reporter.nih.gov |
| The cross-talk between a-Synucleinopathies and T cell immunity in ADRD | NIH | National Institute on Aging | 2024 to 2025 | $1,621,812 | August 15, 2024 | April 30, 2030 | MAO, XIAOBO | reporter.nih.gov |
| MIF Nuclease actions in Synuclein Dementias | NIH | National Institute on Aging | 2024 to 2025 | $1,620,473 | December 1, 2023 | November 30, 2028 | DAWSON, VALINA L. | reporter.nih.gov |
| STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,611,362 | September 30, 2018 | August 31, 2023 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Dendrite regulation by the mitochondrial kinase PINK1: Implications for PD/LBD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,596,950 | September 1, 2017 | June 30, 2029 | CHU, CHARLEEN T | reporter.nih.gov |
| CSF Oligomeric α-synuclein targeted nano scavengers as a Parkinson's disease theranostic | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,585,446 | September 18, 2024 | June 30, 2029 | TANIFUM, ERIC | reporter.nih.gov |
| Investigations of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,574,996 | May 1, 2011 | August 31, 2023 | PERLMUTTER, JOEL SYNES | reporter.nih.gov |
| Changes across the lifespan in the use of heuristics to guide decision-making | NIH | National Institute on Aging | 2022 to 2023 | $1,573,961 | May 1, 2019 | February 28, 2026 | BASSO, MICHELE A | reporter.nih.gov |
| Genome-wide Prediction of Dementia in Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,554,981 | September 20, 2019 | December 31, 2023 | SCHERZER, CLEMENS R | reporter.nih.gov |
| Daily Experiences and Well-being among Caregivers for Older Adults Experiencing Lewy Body Dementia. | NIH | National Institute on Aging | 2024 to 2025 | $1,553,585 | May 1, 2024 | February 28, 2029 | FINGERMAN, KAREN L | reporter.nih.gov |
| Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder | NIH | National Institute on Aging | 2023 to 2024 | $1,549,576 | September 1, 2023 | August 31, 2028 | HOWELL, MICHAEL J | reporter.nih.gov |
| Elucidating the Pathomechanisms of APOE4 in Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,538,709 | July 1, 2024 | March 31, 2029 | ZHAO, NA | reporter.nih.gov |
| Lewy Body Dementia Biomarkers | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,536,368 | September 25, 2016 | November 30, 2023 | FREY, KIRK A. | reporter.nih.gov |
| NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESE NEUROTOXICITY | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,525,888 | September 12, 2019 | May 31, 2024 | CRISWELL, SUSAN | reporter.nih.gov |
| Mechanisms of spreading proteinopathy in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,512,234 | September 15, 2021 | August 31, 2024 | UNNI, VIVEK | reporter.nih.gov |
| Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,505,046 | September 25, 2024 | July 31, 2030 | GALLAGHER, CATHERINE L. | reporter.nih.gov |
| Mitochondrial Sirtuin 3 in Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,499,835 | June 1, 2019 | May 31, 2025 | MCLEAN, PAMELA J | reporter.nih.gov |
| Genome-Wide Prediction of Dementia in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,487,365 | September 20, 2019 | December 31, 2026 | SCHERZER, CLEMENS R | reporter.nih.gov |
| Understanding biomarkers of cognitive decline in Lewy body diseases | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,481,568 | September 19, 2019 | June 30, 2026 | CHEN-PLOTKIN, ALICE S | reporter.nih.gov |
| Molecular and Network Analyses of Lewy Body Dementia Pathogenesis | NIH | National Institute on Aging | 2024 to 2025 | $1,448,065 | September 5, 2021 | August 31, 2027 | CHIN, LIH-SHEN | reporter.nih.gov |
| Role of Rab27b in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,433,631 | September 1, 2021 | August 31, 2024 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,431,052 | August 1, 2021 | July 31, 2027 | NAKAMURA, TOMOHIRO | reporter.nih.gov |
| Mechanistic Dissection of Lipase (LIPE) Regulation of Fatty Acid Homeostasis as a Parkinson's Disease and Lewy Body Dementia Therapeutic Strategy | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,408,421 | June 1, 2024 | May 31, 2029 | FANNING, SARANNA | reporter.nih.gov |
| Pathophysiologic roles of alpha-synuclein at the synapse | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,394,015 | August 15, 2019 | May 31, 2025 | ROY, SUBHOJIT | reporter.nih.gov |
| The Role of Aberrant Histone Acetylation in the Pathogenesis of Parkinson’s Disease and Related Synucleinopathies. | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,366,666 | July 17, 2024 | June 30, 2028 | SOLDNER, FRANK | reporter.nih.gov |
| Effects of 14-3-3θ phosphorylation vesicular transport and alpha-synuclein aggregation | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,361,977 | June 1, 2025 | May 31, 2027 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| Synthetic protein mimetics as potential therapeutics for Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,360,513 | September 19, 2024 | February 28, 2027 | KUMAR, SUNIL | reporter.nih.gov |
| Biologically Novel Mouse Models of PD with Progressive Synucleinopathy and Early-Onset Tremor and Motor Deficits Responsive to L-DOPA | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,344,552 | May 15, 2019 | June 30, 2027 | NUBER, SILKE | reporter.nih.gov |
| Role of altered gut immune response in Lewy Body Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,338,898 | September 1, 2024 | June 30, 2029 | POSTON, KATHLEEN LOMBARD | reporter.nih.gov |
| The Role of GPNMB in Parkinson's Disease. | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,312,338 | August 1, 2024 | June 30, 2029 | SOLDNER, FRANK | reporter.nih.gov |
| Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimer’s Disease | NIH | National Institute on Aging | 2024 to 2025 | $1,310,770 | June 15, 2024 | May 31, 2029 | GERHARDT, GREG A. | reporter.nih.gov |
| Intrinsically disordered domains of α-synuclein: effect of fibril formation and fibril polymorphs | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,287,494 | April 1, 2024 | March 31, 2029 | SIEMER, ANSGAR B | reporter.nih.gov |
| Systematic investigation of disease-associated, regulatory variation; illuminating their prediction, molecular consequences and mechanisms contributing to risk of Parkinson disease (PD) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,260,922 | July 22, 2024 | June 30, 2029 | MCCALLION, ANDREW S | reporter.nih.gov |
| Dementia with Lewy Bodies Consortium | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,215,498 | September 1, 2025 | August 31, 2028 | LEVERENZ, JAMES BRUCE | reporter.nih.gov |
| PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for SmallBusiness Innovation Research Grant Applications (Parent SBIR [R43/R44] ClinicalTrial Not Allowed | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,198,087 | September 30, 2020 | August 31, 2023 | LEVINE, TODD | reporter.nih.gov |
| Frontal midline delta/theta rhythms and cognitive control in PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,156,742 | September 25, 2017 | December 31, 2029 | NARAYANAN, NANDAKUMAR | reporter.nih.gov |
| Prevention of complement and immune-mediated Lewy body dementia | NIH | National Institute on Aging | 2021 to 2022 | $1,133,146 | August 15, 2018 | April 30, 2023 | ISACSON, OLE | reporter.nih.gov |
| Intersection of GBA and LRRK2 in Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,127,274 | July 15, 2024 | April 30, 2029 | LAVOIE, MATTHEW J | reporter.nih.gov |
| Molecular mechanisms of alpha-synuclein induction and spread of pathobiology | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,123,395 | March 1, 2023 | February 28, 2026 | GIASSON, BENOIT I | reporter.nih.gov |
| Mechanisms of Synaptic Dysfunction in Parkinson s and Other Synuclein-Linked Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,117,086 | January 15, 2012 | May 31, 2027 | MORGAN, JENNIFER REBECCA | reporter.nih.gov |
| Tau-dependent cognitive deficits in alpha-synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,101,680 | May 15, 2018 | February 28, 2025 | LEE, MICHAEL K | reporter.nih.gov |
| PROTEOMIC MAPPING OF PATHOLOGICAL INTERACTIONS ACROSS THE SYNUCLEINOPATHY BRAIN | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,027,000 | August 15, 2022 | November 30, 2025 | KILLINGER, BRYAN | reporter.nih.gov |
| Mechanisms of spreading proteinopathy in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,026,156 | September 15, 2021 | August 31, 2027 | UNNI, VIVEK | reporter.nih.gov |
| Simple, Home-use, neurostimulAtion tReatment for Parkinson's disease dEmeNtia (SHARPEN) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $994,322 | July 15, 2023 | April 2, 2025 | FOSTER, KRISTEN KATHLEEN | reporter.nih.gov |
| Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinsons disease. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $956,383 | September 1, 2020 | September 30, 2022 | MISHRA, VIRENDRA R | reporter.nih.gov |
| Role of the endolysosomal pathway in Lewy body dementia - from population genomics to single cells | NIH | National Institute on Aging | 2021 | $949,468 | July 1, 2021 | June 30, 2023 | BRAS, JOSE | reporter.nih.gov |
| a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $901,300 | September 1, 2001 | May 31, 2023 | RISSMAN, ROBERT | reporter.nih.gov |
| Multi-Stakeholder Engagement for Interdisciplinary Telehealth in Lewy Body Dementia | NIH | National Institute on Aging | 2021 to 2025 | $857,616 | September 30, 2021 | May 31, 2027 | PATEL, BHAVANA | reporter.nih.gov |
| RNA Targeted Drug Discovery and Development for Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $851,067 | June 1, 2021 | May 31, 2023 | MOURADIAN, M. MARAL | reporter.nih.gov |
| Slow wave sleep as a biomarker of rehabilitation-induced cognitive improvement in Parkinson's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $843,021 | April 1, 2021 | October 31, 2022 | AMARA, AMY WILLIS | reporter.nih.gov |
| Alpha-Synuclein Induced Network Hyperexcitability in Lewy Body Dementias | NIH | National Institute on Aging | 2021 | $840,282 | September 30, 2021 | August 31, 2023 | VOSSEL, KEITH ALAN | reporter.nih.gov |
| Pathological and cognitive correlations of real time quaking induced conversion in LBD and AD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $828,489 | July 15, 2021 | June 30, 2027 | COUGHLIN, DAVID G | reporter.nih.gov |
| Changes in synaptic vesicle-binding of alpha-synuclein as an early biomarker for synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $793,535 | December 1, 2024 | November 30, 2029 | BURRE, JACQUELINE | reporter.nih.gov |
| The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $793,430 | September 15, 2020 | June 30, 2025 | TROPEA, THOMAS FRANCIS | reporter.nih.gov |
| Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $787,249 | August 15, 2022 | July 31, 2027 | MACKINNON, COLUM D | reporter.nih.gov |
| Contribution of transcriptional mutagenesis of oxidative DNA lesions to generatingnew mutant alpha-synuclein species and aggregation toward the pathogenesis of Parkinson'sdisease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $785,000 | May 15, 2018 | April 30, 2024 | KIM, YOON-SEONG | reporter.nih.gov |
| The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $783,258 | April 15, 2022 | March 31, 2027 | BURRE, JACQUELINE | reporter.nih.gov |
| Identifying Pathophysiological Signatures of DLB Cognitive and Neuropsychiatric Decline Using a Systems-Based Proteomic Approach | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $780,624 | March 1, 2022 | February 28, 2027 | HIGGINBOTHAM, LENORA | reporter.nih.gov |
| Imaging Epigenetic Mechanisms in the Lewy Body Dementias with [11C]Martinostat | NIH | National Institute on Aging | 2021 | $776,355 | September 30, 2021 | August 31, 2023 | GOMPERTS, STEPHEN N. | reporter.nih.gov |
| Cognitive and Affective Network Dysfunction and Neuromodulation in Aging and Synucleinopathy | NIH | National Institute on Aging | 2021 to 2025 | $772,200 | May 1, 2021 | April 30, 2026 | BURNS, MATTHEW ROBERT | reporter.nih.gov |
| Dissecting the Etiology of The Lewy Body Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $764,836 | May 1, 2022 | April 30, 2027 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Prion and non-prion induction mechanisms of alpha-synuclein pathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $759,146 | September 15, 2018 | June 30, 2025 | GIASSON, BENOIT I | reporter.nih.gov |
| The functional role of MAST1 in mediating a-synucleinopathies and related dementia | NIH | National Cancer Institute | 2021 | $749,756 | February 10, 2020 | December 31, 2021 | JIN, LINGTAO | reporter.nih.gov |
| ASC oligomerization and transmission as an initiating event for protein aggregation in Synucleinopathy Dementias | NIH | National Institute on Aging | 2022 to 2024 | $746,997 | September 1, 2022 | August 31, 2025 | PANICKER, NIKHIL | reporter.nih.gov |
| Role of presynaptic targeting of alpha-synuclein in the pathogenesis of Parkinson's Disease and Dementia with Lewy Bodies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $742,500 | May 1, 2018 | February 28, 2023 | VOLPICELLI-DALEY, LAURA A. | reporter.nih.gov |
| Higher Order Convolutional Neural Network for Classification of Lewy-body Diseases and Alzheimers Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $735,100 | February 15, 2022 | January 31, 2027 | VEMURI, BABA C | reporter.nih.gov |
| Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $734,434 | March 1, 2022 | February 28, 2027 | MAITI, BAIJAYANTA | reporter.nih.gov |
| Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $732,992 | June 20, 2025 | March 31, 2030 | BARRETT, MATTHEW JAMES | reporter.nih.gov |
| Plasma Cell-Free RNA as Non-invasive Biomarker for Neurodegeneration | NIH | National Institute on Aging | 2022 to 2024 | $729,126 | February 1, 2020 | March 31, 2026 | IBANEZ, LAURA | reporter.nih.gov |
| Studying Aggregation in Neurodegenerative Disease Using Synthetic Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $721,970 | February 15, 2019 | August 6, 2023 | PETERSSON, ERNEST JAMES | reporter.nih.gov |
| Changes across the lifespan in the use of heuristics to guide decision-making | NIH | National Institute on Aging | 2021 | $711,784 | May 1, 2019 | October 15, 2021 | BASSO, MICHELE A | reporter.nih.gov |
| Higher Order Convolutional Neural Network for Classification of Lewy-body Diseases and Alzheimers Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $702,265 | February 15, 2022 | January 31, 2024 | VEMURI, BABA C | reporter.nih.gov |
| Polo-like-kinase-2-dependent α-Synuclein Serine-129 Phosphorylation: a Physiological RoleDuring Synaptic Activity | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $694,072 | July 15, 2022 | April 30, 2027 | DETTMER, ULF | reporter.nih.gov |
| Expanding Mentorship and Neuroimaging Expertise in Patient-Oriented Studies of Brain, Behavior, and Age-Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $684,120 | September 10, 2020 | April 30, 2026 | CLAASSEN, DANIEL OLIVER | reporter.nih.gov |
| Theta burst subthalamic nucleus deep brain stimulation for cognitive and motor improvements in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $682,922 | September 18, 2024 | August 31, 2029 | LEE, DARRIN JASON | reporter.nih.gov |
| Theta burst subthalamic nucleus deep brain stimulation for cognitive and motor improvements in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $678,336 | September 1, 2025 | August 31, 2029 | LEE, DARRIN JASON | reporter.nih.gov |
| α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $673,092 | March 1, 2022 | February 28, 2027 | MAO, XIAOBO | reporter.nih.gov |
| The role of microglia in Parkinson's disease cognitive and motor impairment | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $670,600 | January 1, 2025 | December 31, 2029 | MILLS, KELLY ALEXANDER | reporter.nih.gov |
| Midcareer Development Award in Neuroaging and Geriatric Pharmacoepidemiology Research | NIH | National Institute on Aging | 2022 to 2025 | $647,532 | March 1, 2022 | February 28, 2027 | WILLIS, ALLISON | reporter.nih.gov |
| Characterization and targeting of a novel pathway promoting Parkinson’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $647,116 | August 15, 2023 | July 31, 2025 | LAWRENCE, DANIEL A | reporter.nih.gov |
| Examining the role of phosphatidylethanolamine and autophagic disruption in Lewy Body Dementias and Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $642,408 | August 1, 2021 | January 31, 2024 | WITT, STEPHAN N. | reporter.nih.gov |
| Dysregulation of Histone Acetylation in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $624,231 | July 11, 2023 | June 30, 2025 | SOLDNER, FRANK | reporter.nih.gov |
| Build-up of beta-amyloid in the brain in Parkinson's disease | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $605,764 | July 1, 2022 | December 31, 2026 | INYUSHIN, MIKHAIL | reporter.nih.gov |
| Genome Wide Analysis of Alpha-Synuclein Neurotoxicity | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $585,729 | September 25, 2017 | June 30, 2024 | FEANY, MEL B | reporter.nih.gov |
| Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies | NIH | National Institute on Aging | 2024 | $578,101 | May 15, 2021 | June 1, 2024 | RISSMAN, ROBERT | reporter.nih.gov |
| Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2024 | $568,772 | September 15, 2020 | May 31, 2025 | KLUGER, BENZI M | reporter.nih.gov |
| Speech markers of cognitive impairment in Parkinson's disease | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2023 | $567,618 | March 4, 2019 | February 28, 2025 | SMITH, KARA MICHELLE | reporter.nih.gov |
| A multiplexable in vivo perturbation toolkit to identify genes affecting neurodegeneration in a model of synucleinopathy | NIH | National Institute on Aging | 2023 to 2024 | $554,302 | September 30, 2023 | September 29, 2025 | PRZEDBORSKI, SERGE E | reporter.nih.gov |
| Screening for Compounds that Lower Intracellular Alpha-Synuclein Levels | NIH | National Institute on Aging | 2021 to 2022 | $553,315 | May 15, 2021 | April 30, 2024 | JOHN, VARGHESE | reporter.nih.gov |
| Developing an Individualized Deep Connectome Framework for ADRD Analysis | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $538,572 | August 18, 2022 | May 31, 2027 | ZHU, DAJIANG | reporter.nih.gov |
| Mechanistic Investigation of Neuropathological Interactions between COVID-19 and Progression of Lewy Pathology and Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $506,052 | August 1, 2024 | July 31, 2025 | LU, XIAOHONG | reporter.nih.gov |
| Contrasting pathomechanisms of membrane versus cytosol alpha-synuclein excess | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $504,625 | April 1, 2021 | September 30, 2023 | DETTMER, ULF | reporter.nih.gov |
| Free water imaging in PD | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $501,220 | May 1, 2023 | April 30, 2025 | POSTON, KATHLEEN LOMBARD | reporter.nih.gov |
| Digital Accessible Remote Olfactory Mediated Health Assessments for Lewy Body Disease | NIH | National Institute on Aging | 2025 | $493,964 | September 10, 2025 | July 31, 2027 | REINEKE, SEAN | reporter.nih.gov |
| Genetic and Neuropathologic Underpinnings of Sex Differences in Lewy Body Dementias | NIH | National Institute on Aging | 2024 to 2025 | $485,710 | July 1, 2022 | July 31, 2027 | BAYRAM, ECE | reporter.nih.gov |
| Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies | NIH | National Institute on Aging | 2025 | $485,466 | May 15, 2021 | April 30, 2026 | RISSMAN, ROBERT | reporter.nih.gov |
| Investigating how the microbiota modulates neuroinflammatory signaling and neurodegeneration in Parkinson's disease and dementia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $482,138 | September 6, 2022 | August 31, 2024 | KORECKA-ROET, JOANNA ALEKSANDRA | reporter.nih.gov |
| NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY | NIH | National Institute of Environmental Health Sciences | 2023 | $475,542 | September 12, 2019 | May 31, 2025 | CRISWELL, SUSAN | reporter.nih.gov |
| Functional MRI Biomarkers Predicting Cognitive Progression in PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $473,603 | August 15, 2017 | May 31, 2023 | HANNA-PLADDY, BRENDA | reporter.nih.gov |
| Synaptic vesicle changes in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $464,014 | July 1, 2022 | June 30, 2025 | BURRE, JACQUELINE | reporter.nih.gov |
| Shedding light on functional heterogeneity of dementia-related alpha-synuclein strains | NIH | National Institute on Aging | 2022 | $463,124 | August 15, 2022 | July 31, 2025 | LIANG, YAJIE | reporter.nih.gov |
| Role of Rab27b in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $462,037 | September 1, 2021 | August 31, 2025 | YACOUBIAN, TALENE ALENE | reporter.nih.gov |
| Role of LRP10 in Parkinson's disease and dementia: a knockout mouse model | NIH | National Institute on Aging | 2025 | $457,875 | May 1, 2025 | April 30, 2027 | XIONG, YULAN | reporter.nih.gov |
| Neurodegeneration and Neuronal Fluctuations in DLB and AD | NIH | National Institute on Aging | 2023 to 2025 | $456,570 | July 5, 2023 | May 31, 2027 | CHIU, SHANNON | reporter.nih.gov |
| Integrative analysis of proteomics and transcriptomics to delineate vesicular transport related protein abnormalities related to Alzheimer's, Lewy body and mixed Pathologies | NIH | National Institute on Aging | 2022 | $455,583 | June 1, 2022 | May 31, 2025 | PILLAI, JAGAN AYYAPPAN | reporter.nih.gov |
| Chaperone protection in Lewy body and Alzheimer’s dementias: determining the structural, molecular and cellular mechanisms of a novel, non-canonical Hsp70 action blocking a-synuclein oligomerization | NIH | National Institute on Aging | 2023 to 2024 | $453,845 | April 15, 2023 | March 31, 2026 | MCCONLOGUE, LISA C | reporter.nih.gov |
| Design and characterization of Nanobodies to dementia-related α-synuclein strains in Parkinson’s disease | NIH | National Institute on Aging | 2021 | $453,658 | June 1, 2021 | May 31, 2023 | WANG, WENJING | reporter.nih.gov |
| Chemical Fingerprints of Cognitive Impairment-related alpha-Synuclein Strains using 3D Small Molecule Microarray and Related Therapeutic Application | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $450,313 | February 15, 2022 | January 31, 2024 | MAO, XIAOBO | reporter.nih.gov |
| Myelination and Resilience Against Limbic Alpha-Synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $447,461 | September 26, 2022 | August 31, 2025 | LEAK, REHANA KHAN | reporter.nih.gov |
| Use of machine learning to quantify cognitive function in AD, FTD, and DLB | NIH | National Institute on Aging | 2021 to 2022 | $443,109 | August 1, 2021 | November 30, 2023 | DICKERSON, BRADFORD C | reporter.nih.gov |
| Defining The Substrates of Acyl Protein Thioesterase-1: Their Role in Modulating Alpha-Synuclein Toxicity | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $441,690 | July 1, 2024 | June 30, 2026 | HO, GARY P. H. | reporter.nih.gov |
| Exploring the differential spreading of distinct pathological conformers of AD/LBD-related proteins by combining mathematical modeling and functional study | NIH | National Institute on Aging | 2024 to 2025 | $440,931 | September 1, 2024 | June 30, 2026 | RAJ, ASHISH | reporter.nih.gov |
| Factors Associated with Healthcare Utilization Among Community-Dwelling Adults with Clinical Features of Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 | $440,890 | September 30, 2021 | August 31, 2024 | WYMAN-CHICK, KATHRYN A | reporter.nih.gov |
| Non-Contrast-Enhanced MRI for Brain Perfusion Mapping of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $440,126 | September 17, 2024 | July 31, 2029 | ZHU, DAN | reporter.nih.gov |
| Multiclass classification under prioritized error control and specific error costs with applications to dementia classification | NIH | National Institute on Aging | 2021 to 2022 | $438,473 | September 1, 2021 | May 31, 2024 | FENG, YANG | reporter.nih.gov |
| Impact of actin binding protein Coronin 1C in the pathogenesis of Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $432,850 | February 15, 2022 | January 31, 2025 | SCHUELE, BIRGITT | reporter.nih.gov |
| Role of Transglutaminase 2 in Synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $431,750 | July 1, 2021 | December 31, 2023 | MOURADIAN, M. MARAL | reporter.nih.gov |
| Exploring The Brain Enriched E3 Ubiquitin Ligase TRIM9 in Alzheimer's Disease | NIH | National Institute on Aging | 2022 | $427,625 | May 15, 2022 | April 30, 2025 | GUPTON, STEPHANIE | reporter.nih.gov |
| Development and characterization of EEG signature of cognitive fluctuations in Lewy body dementia | NIH | National Institute on Aging | 2022 | $426,938 | June 15, 2022 | May 31, 2025 | BARRETT, MATTHEW JAMES | reporter.nih.gov |
| Transcriptomic assessment of pathology in PD with dementia and dementia with Lewy Bodies using iPSC neurons and brain tissue of the same individuals | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $423,274 | August 15, 2022 | July 31, 2025 | SATTLER, RITA | reporter.nih.gov |
| Non-Contrast-Enhanced MRI for Brain Perfusion Mapping of Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $420,683 | September 17, 2024 | July 31, 2029 | ZHU, DAN | reporter.nih.gov |
| Repopulation of the Microglia/Macrophage Niche in Experimental Lewy Body Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $420,078 | September 17, 2024 | August 31, 2027 | LEAK, REHANA K | reporter.nih.gov |
| The Norepinephrine transporter as a therapeutic target for treatment of alpha-synuclein pathology in PD | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $419,375 | May 1, 2021 | December 31, 2023 | URS, NIKHIL | reporter.nih.gov |
| Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy? | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $419,375 | June 15, 2023 | May 31, 2026 | VEDAM-MAI, VINATA | reporter.nih.gov |
| Dnajc13 p.N860S as a physiologic model ofalpha-Synuclein overexpression | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $419,375 | May 15, 2024 | April 30, 2027 | FARRER, MATTHEW J | reporter.nih.gov |
| Effects of Cognitive Training on Everyday Cognitive and Brain Function in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $418,750 | July 10, 2023 | December 31, 2024 | TINAZ, SULE | reporter.nih.gov |
| PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $411,687 | May 1, 2017 | April 30, 2023 | MOURADIAN, M. MARAL | reporter.nih.gov |
| A new in vivo zebrafish model to study alpha-synuclein aggregation in Lewy Body Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $411,150 | June 1, 2023 | May 31, 2026 | WEISSMAN, TAMILY A | reporter.nih.gov |
| The interactions between myenteric macrophages and enteric neurons shape development and spread of enteric synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $408,057 | July 1, 2023 | June 30, 2025 | KHOSHBOUEI, HABIBEH | reporter.nih.gov |
| Optical Sensing of the Spread of Alpha-Synuclein Aggregates in Models of Parkinson's Disease and Related Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $406,260 | July 5, 2024 | June 30, 2026 | WEBB, KEVIN J | reporter.nih.gov |
| Activity-dependent release of human alpha-synuclein | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $403,010 | February 1, 2023 | January 31, 2026 | LEE, DAEWOO | reporter.nih.gov |
| Mapping Brain Lipid Architecture in Aging, LBD and T Cell Therapy using novel Imaging Mass Spectrometry | NIH | National Institute on Aging | 2024 | $400,707 | September 1, 2024 | August 31, 2026 | VEDAM-MAI, VINATA | reporter.nih.gov |
| Commercial production of alpha-synuclein fibrils amplified from human postmortem brain tissue to expand the availability of a critical research tool for Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $395,951 | September 19, 2025 | August 31, 2026 | KOTZBAUER, PAUL T | reporter.nih.gov |
| Improving End-of-Life Care for Hospitalized Patients with Lewy Body Disorders | NIH | National Institute on Aging | 2024 to 2025 | $389,880 | September 3, 2024 | June 30, 2029 | AAMODT, WHITLEY | reporter.nih.gov |
| Stabilizing native α-synuclein homeostasis to prevent insoluble α-synuclein aggregates | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $386,653 | August 1, 2017 | May 31, 2023 | DETTMER, ULF | reporter.nih.gov |
| Mechanisms of Neurodegeneration in Lewy Body Disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $385,000 | July 1, 2017 | March 31, 2023 | UNNI, VIVEK | reporter.nih.gov |
| Cortical Mechanisms in Lewy Body Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $375,408 | September 18, 2018 | June 30, 2023 | ALDRIDGE, GEORGINA | reporter.nih.gov |
| Cerebrovascular contributions to cognitive impairment in Lewy body dementias | NIH | National Institute on Aging | 2022 to 2023 | $362,000 | February 15, 2022 | January 31, 2026 | RYMAN, SEPHIRA | reporter.nih.gov |
| Deep brain stimulation of the Nucleus Basalis of Meynert: the role of stimulation parameters in neurogenesis and cognitive recovery. | NIH | National Institute on Aging | 2022 to 2023 | $292,000 | February 1, 2022 | November 30, 2025 | KUMBHARE, DEEPAK | reporter.nih.gov |
| Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia | NIH | National Institute on Aging | 2021 to 2022 | $291,000 | January 15, 2021 | December 31, 2022 | NORTH, BRIAN J. | reporter.nih.gov |
| Prototype Multimedia ADRD Falls Prevention System for Family Caregivers | NIH | National Institute on Aging | 2021 to 2022 | $274,754 | June 1, 2021 | May 31, 2022 | PANZER, VICTORIA P | reporter.nih.gov |
| Genetic and Neuropathologic Underpinnings of Sex Differences in Lewy Body Dementias | NIH | National Institute on Aging | 2022 to 2023 | $250,502 | July 1, 2022 | June 30, 2024 | BAYRAM, ECE | reporter.nih.gov |
| Mechanisms of Endosomal Dysfunction at Synapses in A-Synuclein Pathology | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $248,538 | July 1, 2023 | June 30, 2025 | ROMAN-VENDRELL, CRISTINA | reporter.nih.gov |
| Remote monitoring using commercially available activity trackers and computer vision provides a holistic, low-cost assessment of Parkinson’s disease symptoms | NIH | National Institute on Aging | 2024 to 2025 | $244,569 | August 9, 2024 | April 30, 2029 | SIMMERING, JACOB | reporter.nih.gov |
| Metals Exposure, Dementia, and Longitudinal Trajectories of Cognition, Functioning, and Neuropsychiatric Symptoms | NIH | National Institute on Aging | 2024 to 2025 | $240,972 | August 9, 2024 | May 31, 2029 | WANG, XIN | reporter.nih.gov |
| Building Capacity to Meet the Palliative Care Needs of People with Parkinson Disease, Lewy Body Dementia and Related Disorders living in Black and Hispanic Communities | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $231,000 | March 1, 2025 | January 31, 2028 | KLUGER, BENZI M | reporter.nih.gov |
| Antihypertensives and the Aging Brain | NIH | National Institute on Aging | 2021 | $227,908 | August 1, 2019 | July 31, 2022 | MARCUM, ZACHARY ADAM | reporter.nih.gov |
| Distinguishing α-Synuclein S129 Phosphorylation in Health and Lewy Body Dementia | NIH | National Institute on Aging | 2024 to 2025 | $223,751 | August 15, 2024 | January 4, 2026 | RAMALINGAM, NAGENDRAN | reporter.nih.gov |
| Competence, Autonomy, Relatedness, and Connections (CARe Connections): A Peer-Led Intervention Designed with Parkinsons Disease & Related Disorders Carepartners to Improve Holistic Support | NIH | National Institute on Aging | 2024 to 2025 | $217,186 | September 1, 2024 | June 30, 2029 | SESHADRI, SANDHYA | reporter.nih.gov |
| Metabolo-Genetic Dissection of GBA and Lysosomal Genes in Parkinson's Disease and Lewy Body Dementia | NIH | National Institute on Aging | 2021 | $200,000 | August 1, 2020 | April 30, 2023 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Mechanisms for Preserving Neurons in Alzheimer's Disease-Related Dementias Across Drosophila and Mouse Models | NIH | National Institute on Aging | 2021 | $195,625 | September 30, 2020 | June 30, 2023 | FREYBERG, ZACHARY | reporter.nih.gov |
| Mechanism and importance of innate immune activation in a Drosophila GBA mutant model of Parkinson's disease | NIH | National Institute on Aging | 2021 | $194,375 | September 10, 2020 | May 31, 2023 | PALLANCK, LEO J | reporter.nih.gov |
| Parkinson disease and DBS: cognitive effects in GBA mutation carriers | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $182,410 | July 1, 2017 | May 31, 2023 | PAL, GIAN D | reporter.nih.gov |
| Neurodegeneration and Neuronal Fluctuations in DLB and AD | NIH | National Institute on Aging | 2022 to 2023 | $165,479 | June 1, 2022 | July 1, 2023 | CHIU, SHANNON | reporter.nih.gov |
| ApoE Regulation of Alpha-Synuclein Pathology in Parkinson Disease Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $165,255 | July 1, 2017 | June 30, 2022 | DAVIS, ALBERT A | reporter.nih.gov |
| Validation of Small Molecule Enhancers of Mutant Glucocerebrosidase 1 Activity | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $163,750 | July 1, 2024 | June 30, 2026 | KO, HANSEOK | reporter.nih.gov |
| Phase 2 Development of a Spoken Language Biomarker of Cognitive Impairment in Parkinson's Disease | NIH | National Institute on Deafness and Other Communication Disorders | 2021 | $158,059 | May 1, 2019 | April 30, 2024 | ROBERTS, ANGELA CHRISTINE | reporter.nih.gov |
| Structural Biology and Biophysics of Alpha-Synuclein Fibrils by Solid-State NMR | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $143,364 | April 1, 2023 | March 31, 2025 | BORCIK, COLLIN GRIFFIN | reporter.nih.gov |
| Role of 14-3-3θ in Environmental Toxicant Exposure and Neuroinflammation in Synucleinopathies | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $142,016 | August 1, 2023 | July 31, 2027 | STONE, WILLIAM J | reporter.nih.gov |
| ASC oligomerization and transmission as an initiating event for protein aggregation in Synucleinopathy Dementias | NIH | National Institute on Aging | 2021 | $135,540 | May 1, 2020 | April 30, 2022 | PANICKER, NIKHIL | reporter.nih.gov |
| Investigating the Role of Myenteric Macrophages in Enteric Synucleinopathy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $135,357 | May 16, 2023 | March 15, 2026 | MACKIE, PHILLIP | reporter.nih.gov |
| Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism | NIH | National Institute on Aging | 2021 | $130,140 | September 15, 2017 | February 28, 2022 | MAO, XIAOBO | reporter.nih.gov |
| Plasma Cell-Free RNA as Non-invasive Biomarker for Neurodegeneration | NIH | National Institute on Aging | 2021 | $125,096 | February 1, 2020 | January 31, 2022 | IBANEZ, LAURA | reporter.nih.gov |
| Determining the Interacting Effects of GBA, SNCA, and APOE on a-Synuclein Pathology Severity in Dementia with Lewy Bodies and Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $115,628 | January 1, 2023 | October 30, 2025 | GOLDMAN, CAMILLE | reporter.nih.gov |
| Investigating Histone 3 Dopaminylation in Parkinson's Disease | NIH | National Institute on Aging | 2024 to 2025 | $96,752 | September 9, 2024 | September 8, 2028 | CHEN, WINNIE | reporter.nih.gov |
| Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $84,542 | January 1, 2024 | December 31, 2027 | PAIR, FRANK SANDERS | reporter.nih.gov |
| Role of Rab27 Isoforms on Alpha-Synuclein Endocytosis and Clearance | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $81,311 | September 25, 2024 | September 24, 2026 | SCHOLZ, KASANDRA J | reporter.nih.gov |
| The role for cell cycle regulators in trichloroethylene induced Parkinson's dementia | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $81,092 | August 1, 2024 | July 31, 2027 | ADAMSON, ASHLEY | reporter.nih.gov |
| The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies | NIH | National Institute on Aging | 2023 to 2025 | $80,580 | January 1, 2024 | June 30, 2027 | EICHENLAUB, EMILY KATHRYN | reporter.nih.gov |
| The effect of GBA1 L444P heterozygous mutation on synaptic morphology in the hippocampus and cognition related to Lewy body dementias | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $76,846 | July 1, 2022 | June 30, 2024 | MAHONEY-CRANE, CASEY | reporter.nih.gov |
| Nigrostriatal dopamine mechanisms of cognitive control | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $72,011 | August 1, 2023 | July 31, 2024 | BOVA, ALEXANDRA SHELLY | reporter.nih.gov |
| The role of beta-synuclein in synaptic vesicle release | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $68,545 | June 15, 2022 | June 30, 2023 | KOMER, LAUREN | reporter.nih.gov |
| Identifying the genetic basis of variably protease-sensitive prionopathy | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $66,800 | February 1, 2022 | January 31, 2023 | MINIKEL, ERIC VALLABH | reporter.nih.gov |
| Role of Glucosylsphingosine in Parkinson Disease and Dementia with Lewy Bodies | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $63,650 | September 15, 2019 | May 31, 2024 | CHANDRA, SREEGANGA S | reporter.nih.gov |
| Querying the Interactome of Alpha-Synuclein During Pathological Processes | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $49,538 | August 27, 2025 | August 26, 2027 | FERNANDES, ANALIESE | reporter.nih.gov |
| Contribution of the interaction between synuclein and tau in the pathophysiology of dementia with Lewy bodies | NIH | National Institute on Aging | 2021 | $46,585 | September 1, 2018 | August 31, 2022 | STOYKA, LINDSAY ELIZABETH | reporter.nih.gov |
| Combining Chemical Biology and Machine Learning to Generate Reproducible Amyloid Fibrils | NIH | National Institute on Aging | 2024 | $45,304 | September 5, 2024 | September 4, 2025 | PEREZ, RYANN MICHAEL | reporter.nih.gov |
| PINK1 regulates cytoplasmic dynein and mitochondrial transport | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $45,016 | November 1, 2019 | October 31, 2021 | OTERO, PETER ANTHONY | reporter.nih.gov |
| Utilizing microRNA in cerebrospinal fluid to evaluate the effects of tyrosine kinase inhibition via Nilotinib on gene regulation in individuals with Parkinson's disease or Alzheimer's disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $29,116 | July 1, 2020 | August 21, 2021 | FOWLER, ALAN | reporter.nih.gov |
| Cortical Neuronal Vulnerability in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $26,651 | June 1, 2025 | September 26, 2025 | GORALSKI, THOMAS | reporter.nih.gov |
| Deep brain stimulation of the Nucleus Basalis of Meynert: the role of stimulation parameters in neurogenesis and cognitive recovery | NIH | National Institute on Aging | 2022 | $1 | February 1, 2022 | May 15, 2022 | KUMBHARE, DEEPAK | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester, MN | 3 | $33.1 million | 0 | $0 |
| University of Florida | Gainesville, FL | 19 | $29.9 million | 0 | $0 |
| Cognition Therapeutics, Inc. | Pittsburgh, PA | 1 | $29.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 13 | $22.6 million | 0 | $0 |
| Eip Pharma, Inc. | Boston, MA | 1 | $21.1 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 14 | $19.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 14 | $18.1 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 15 | $15.5 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 11 | $14.3 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 5 | $13.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 7 | $12 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 5 | $11.9 million | 0 | $0 |
| Emory University | Atlanta, GA | 4 | $9.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 5 | $8.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 6 | $7.7 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 3 | $7.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 7 | $7.6 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 4 | $6.6 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 4 | $6.5 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 3 | $6.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 4 | $5.8 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 3 | $5.7 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 6 | $5.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 5 | $5.4 million | 0 | $0 |
| Seattle Inst for Biomedical/clinical Res | Seattle, WA | 3 | $5.3 million | 0 | $0 |
| Biosensics, LLC | Newton, MA | 1 | $5.2 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 3 | $4.7 million | 0 | $0 |
| University of Washington | Seattle, WA | 5 | $4.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 5 | $4.5 million | 0 | $0 |
| University of Rochester | Rochester, NY | 4 | $4.5 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 4 | $3.8 million | 0 | $0 |
| Institute for Molecular Medicine | Huntington Beach, CA | 1 | $3.6 million | 0 | $0 |
| CND Life Sciences, Inc. | Scottsdale, AZ | 2 | $3.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 2 | $3.6 million | 0 | $0 |
| Marine Biological Laboratory | Woods Hole, MA | 3 | $3.5 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 3 | $3.3 million | 0 | $0 |
| Georgetown University | Washington, DC | 2 | $3.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 1 | $3.2 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 1 | $3.2 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 2 | $3.1 million | 0 | $0 |
| Brown University | Providence, RI | 1 | $3.1 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 3 | $3.1 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 1 | $3.1 million | 0 | $0 |
| Lovelace Biomedical Research Institute | Albuquerque, NM | 2 | $3 million | 0 | $0 |
| Amydis Diagnostics, Inc. | La Jolla, CA | 1 | $3 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 1 | $3 million | 0 | $0 |
| Advanced Brain Monitoring, Inc. | Carlsbad, CA | 1 | $2.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 3 | $2.9 million | 0 | $0 |
| Neurodex INC | Arlington, MA | 1 | $2.9 million | 0 | $0 |
| Hugo W. Moser Res Inst Kennedy Krieger | Baltimore, MD | 2 | $2.8 million | 0 | $0 |
| Van Andel Research Institute | Grand Rapids, MI | 3 | $2.8 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 1 | $2.7 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 1 | $2.7 million | 0 | $0 |
| Rbhs-Robert Wood Johnson Medical School | Piscataway, NJ | 5 | $2.7 million | 0 | $0 |
| Maphabit, Inc. | Atlanta, GA | 1 | $2.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 2 | $2.6 million | 0 | $0 |
| Banner Health | Phoenix, AZ | 1 | $2.3 million | 0 | $0 |
| University of Texas at Arlington | Arlington, TX | 2 | $2.2 million | 0 | $0 |
| Yale University | New Haven, CT | 3 | $2 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 1 | $1.9 million | 0 | $0 |
| Parabon Nanolabs, Inc. | Reston, VA | 1 | $1.9 million | 0 | $0 |
| Tufts University | Medford, MA | 1 | $1.8 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 2 | $1.8 million | 0 | $0 |
| Lucerna, Inc. | Brooklyn, NY | 1 | $1.7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 1 | $1.7 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 1 | $1.6 million | 0 | $0 |
| Louisiana State Univ HSC Shreveport | Shreveport, LA | 3 | $1.4 million | 0 | $0 |
| University of Denver | Denver, CO | 1 | $1.4 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 1 | $1.3 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 3 | $1.2 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 1 | $1.1 million | 0 | $0 |
| Scion Neurostim, LLC | Durham, NC | 1 | $994,322 | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 2 | $936,727 | 0 | $0 |
| ST. Joseph's Hospital and Medical Center | Phoenix, AZ | 2 | $898,816 | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $894,776 | 0 | $0 |
| Duquesne University | Pittsburgh, PA | 2 | $867,539 | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 1 | $684,120 | 0 | $0 |
| Universidad Central del Caribe | Bayamon, PR | 1 | $605,764 | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 1 | $567,618 | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 2 | $508,205 | 0 | $0 |
| Aromha, Inc. | Potomac, MD | 1 | $493,964 | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 1 | $457,875 | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 1 | $456,570 | 0 | $0 |
| Healthpartners Institute | Bloomington, MN | 1 | $440,890 | 0 | $0 |
| New York University | New York, NY | 1 | $438,473 | 0 | $0 |
| Lewis and Clark College | Portland, OR | 1 | $411,150 | 0 | $0 |
| Purdue University | West Lafayette, IN | 1 | $406,260 | 0 | $0 |
| Ohio University | Athens, OH | 1 | $403,010 | 0 | $0 |
| Helical Biosciences LLC | Saint Louis, MO | 1 | $395,951 | 0 | $0 |
| Creighton University | Omaha, NE | 1 | $291,000 | 0 | $0 |
| Brookside Research & Development Company | Coupeville, WA | 1 | $274,754 | 0 | $0 |
| Northwestern University | Chicago, IL | 1 | $158,059 | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 1 | $66,800 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 116 | $96,807,854 | 0 | $0 |
| 2024 | 127 | $92,072,670 | 0 | $0 |
| 2023 | 118 | $100,735,632 | 0 | $0 |
| 2022 | 116 | $95,732,067 | 0 | $0 |
| 2021 | 104 | $84,369,033 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.